Non-progression of cervical intraepithelial neoplasia estimated from population-screening data

British Journal of Cancer

Volumn 75, Issue 1, 1997, Pages 124-130

  Bos, A B ^a   Van Ballegooijen, M ^a   Van Oortmarssen, G J ^a   Van Marle, M E ^a   Habbema, J D F ^a   Lynge, E ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

Author keywords

Cervical cancer; Dysplasia; Natural history; Pap smear; Screening

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER SCREENING; DENMARK; FEMALE; HUMAN; PAPANICOLAOU TEST; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0031012308     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.20     Document Type: Article

References (20)

1. Berget A (1979) Influence of population screening on morbidity and mortality of cancer of the uterine cervix in Maribo Amt. Dan Med Bull 26: 91-100
2. Boyes DA, Morrison B, Knox EG, Draper FJ and Miller AB (1982) A cohort study of cervical cancer screening in British Columbia. Clin Invest Med 5: 1-29
3. Danmarks Statistik (1995) Vital Statistics 1993. Danmarks Statistik: Copenhagen (in Danish)
4. Doll R, Payne P and Waterhouse J (eds) (1966) Cancer Incidence in Five Continents. A Technical Report. Springer: Berlin.
5. Doll R, Muir C and Waterhouse J (eds) (1970) Cancer incidence in Five Continents. Vol II. Springer: Berlin
6. Gustafsson L and Adami HO (1989). Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer 60: 132-141
7. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes (1986) Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implication for screening programmes. Br Med J 293: 659-664
8. Kleinbaum DG, Kupper LL and Mogenstern H (1982). Epidemiologic Research, Principles and Quantitative Methods, pp. 296-300. Lifetime Learning Publications: London
9. Kurman RJ, Henson DE, Herbst AL, Noller KL and Schiffman MH for The 1992 National Cancer Institute Workshop (1994) Interim guidelines for management of abnormal cervical cytology. JAMA 271: 1866-1869.
10. Lynge F. and Poll P (1986a) Risk of cervical cancer following negative smears in Maribo County, Denmark, 1966-1982. In Screening of Cancer of the Uterine Cervix, Miller AB, Day N, Hakama M (eds) pp. 69-86. International Agency for Research on Cancer: Lyon
11. Lynge E and Poll P (1986b) Incidence of cervical cancer following negative smear. A cohort study from Maribo County, Denmark. Am J Epidemiol 124: 345-352
12. Magnus K, Langmark F and Andersen A (1987) Mass screening for cervical cancer in Ostfold county in Norway 1959-77. Int J Cancer 39: 311-316
13. Oortmarssen GJ Van and Habbema JDF (1991) Epidemiological evidence for age-dependent regression of pro-invasive cervical cancer. Br J Cancer 64: 559-565
14. Oortmarssen GJ Van and Habbema JDF (1995) Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears. Int J Epidemiol 24: 300-307
15. Ostor AG (1993) Natural history of cervical intraepethelial neoplasias; a critical review. Int J Gynecol Pathol 12: 186-192
16. Singer A (1995) Cervical cancer screening: state of the art. Bailliere's Clin Obstet Gynaecol 9(1): 39-64
17. Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J and Powell J (eds) (1992) Cancer Incidence in Five Continents. Vol VI. IARC Scientific Publications; Lyon
18. Pathological National Automated Archive (PALGA) (1992) Results of Retrieval Action on Cervical Cytology from 1987-1990. PALGA: Amsterdam
19. Raffle AH, Alden B and Mackenzie EED (1995) Detection rates for abnormal cervical smears; what are we screening for? Lancet 345: 1469-1473
20. Wilson JMG and Jungner F (1968) Principles and Practice of Screening for Disease. Public Health Papers 34. World Health Organization: Geneva